← FDA Drug Approvals (Drugs@FDA)

CRYSTODIGIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: LILLY · Approved 1978-08-28

Drug application

FDA Application #

ANDA084100

Application type

Abbreviated New Drug Application (Generic)

Brand name

CRYSTODIGIN

Generic name

Digitoxin

Active ingredients

DIGITOXIN

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

LILLY

First approval

1978-08-28

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown